MobiHealth News April 4, 2024
FDA clearance opens US door for European RPM system
Current solutions for remote health monitoring can be seen as invasive by patients and mostly do single variant intermittent tracking. FDA clearance brings one of Europe’s most advanced real-time continuous remote monitoring systems to the US market for the first time.
A patient-friendly multi-sensor bracelet which helps to address some of the key challenges around the adoption of remote patient monitoring systems (RPM) has been given clearance by the United States Food and Drug Administration (FDA).
Corsano Health’s CardioWatch System is an advanced real-time monitoring system, which consists of a bracelet worn by an adult patient (at least 22 years old), a web-based browser, and a mobile app that can operate...
Today's Sponsors
Today's Sponsor